Cancer metabolism collaboration II

Cancer metabolism platform is a novel program aiming at specific modulation of cancer cells. Utilizing the unique set of research tools developed at Selvita, the platform is designed for a rapid evaluation of novel targets and validation of key cancer metabolism enzymes.

The project is executed within second collaboration with Merck KGaA, Germany and its details are strictly confidential.